| 1 | [SID103173276] | Active | Ki | 0.002 | Ability to displace [3H]pyrilamine from histamine H1 receptor in male Sprague-Dawley rat brain membranes [AID87525, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | Ki | 0.002 [uM] | | BioAssay | Ability to displace [3H]pyrilamine from histamine H1 receptor in male Sprague-Dawley rat brain membranes | | AID | 87525 | | BioAssay type | Literature | | Target | | | PubMed | 12781173 | | Data Table |  |
|
| 2 | [SID103173276] | Active | Kd | 0.00398 | pA2 value is determined compared to standard H1-antagonists [AID24863, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | Kd | 0.00398 [uM] | | BioAssay | pA2 value is determined compared to standard H1-antagonists | | AID | 24863 | | BioAssay type | Literature | | Target | | | PubMed | 7562938 | | Data Table |  |
|
| 3 | [SID103173276] | Active | Ki | 0.0055 | Binding affinity against Histamine H1 receptor using receptor binding assay in rat brain membranes [AID87519, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | Ki | 0.0055 [uM] | | BioAssay | Binding affinity against Histamine H1 receptor using receptor binding assay in rat brain membranes | | AID | 87519 | | BioAssay type | Literature | | Target | | | PubMed | 9934454 | | Data Table |  |
|
| 4 | [SID103173276] | Active | Ki | 0.0055 | Binding affinity to histamine H1 receptor in rat brain membranes was evaluated using [3H]-pyrilamine as radioligand [AID87521, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | Ki | 0.0055 [uM] | | BioAssay | Binding affinity to histamine H1 receptor in rat brain membranes was evaluated using [3H]-pyrilamine as radioligand | | AID | 87521 | | BioAssay type | Literature | | Target | | | PubMed | 1671420 | | Data Table |  |
|
| 5 | [SID103173276] | Active | Ki | 0.007 | Binding affinity to histamine H1 receptor [AID591511, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | Ki | 0.007 [uM] | | BioAssay | Binding affinity to histamine H1 receptor | | AID | 591511 | | BioAssay type | Literature | | Target | | | PubMed | 21381763 | | Data Table |  |
|
| 6 | [SID103173276] | Active | IC50 | 0.0088 | Inhibition of [3H]mepyramine binding to the Histamine H1 receptor in guinea pig cortex [AID86586, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 0.0088 [uM] | | BioAssay | Inhibition of [3H]mepyramine binding to the Histamine H1 receptor in guinea pig cortex | | AID | 86586 | | BioAssay type | Literature | | Target | | | PubMed | 1673158 | | Data Table |  |
|
| 7 | [SID103173276] | Active | IC50 | 0.066 | Displacement of [3H]pyrilamine from human histamine receptor subtype 1 expressed in CHO cells [AID351895, Type: Literature] | Histamine H1 receptor [gi:547645] |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 0.066 [uM] | | BioAssay | Displacement of [3H]pyrilamine from human histamine receptor subtype 1 expressed in CHO cells | | AID | 351895 | | BioAssay type | Literature | | Target | Histamine H1 receptor [gi:547645] | | PubMed | 17846138 | | Data Table |  |
|
| 8 | [SID103173276] | Active | IC50 | 0.066 | Displacement of [3H]pyrilamine from human histamine receptor subtype 1 expressed in CHO cells [AID351895, Type: Literature] | Histamine H1 receptor [gi:547645] |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 0.066 [uM] | | BioAssay | Displacement of [3H]pyrilamine from human histamine receptor subtype 1 expressed in CHO cells | | AID | 351895 | | BioAssay type | Literature | | Target | Histamine H1 receptor [gi:547645] | | PubMed | 17846138 | | Data Table |  |
|
| 9 | [SID103173276] | Active | IC50 | 1.1 | Inhibitory concentration against IKr potassium channel [AID240820, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 1.1 [uM] | | BioAssay | Inhibitory concentration against IKr potassium channel | | AID | 240820 | | BioAssay type | Literature | | Target | | | PubMed | 15324906 | | Data Table |  |
|
| 10 | [SID103173276] | Active | IC50 | 3.9 | Antimalarial activity after 72 hrs against chloroquine-resistant Plasmodium falciparum Dd2 infected human erythrocytes by SYBR green assay [AID351890, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 3.9 [uM] | | BioAssay | Antimalarial activity after 72 hrs against chloroquine-resistant Plasmodium falciparum Dd2 infected human erythrocytes by SYBR green assay | | AID | 351890 | | BioAssay type | Literature | | Target | | | PubMed | 17846138 | | Data Table |  |
|
| 11 | [SID103173276] | Active | IC50 | 10 | Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex [AID205267, Type: Literature] | |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 10 [uM] | | BioAssay | Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex | | AID | 205267 | | BioAssay type | Literature | | Target | | | PubMed | 2579237 | | Data Table |  |
|
| 12 | [SID103173276] | Active | IC50 | 20.893 | Inhibitory concentration against potassium channel HERG [AID243151, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 20.893 [uM] | | BioAssay | Inhibitory concentration against potassium channel HERG | | AID | 243151 | | BioAssay type | Literature | | Target | | | PubMed | 15911273 | | Data Table |  |
|
| 13 | [SID103173276] | Active | IC50 | 20.893 | Inhibition of human ERG [AID576612, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 20.893 [uM] | | BioAssay | Inhibition of human ERG | | AID | 576612 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 21185626 | | Data Table |  |
|
| 14 | [SID103173276] | Active | IC50 | 20.893 | Inhibition of human ERG [AID576612, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 20.893 [uM] | | BioAssay | Inhibition of human ERG | | AID | 576612 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 21185626 | | Data Table |  |
|
| 15 | [SID103173276] | Active | IC50 | 20.893 | Inhibition of human ERG [AID576612, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 20.893 [uM] | | BioAssay | Inhibition of human ERG | | AID | 576612 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 21185626 | | Data Table |  |
|
| 16 | [SID103173276] | Active | IC50 | 20.893 | Inhibition of human ERG [AID576612, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 20.893 [uM] | | BioAssay | Inhibition of human ERG | | AID | 576612 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 21185626 | | Data Table |  |
|
| 17 | [SID103173276] | Active | IC50 | 20.893 | Inhibition of human ERG [AID576612, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 20.893 [uM] | | BioAssay | Inhibition of human ERG | | AID | 576612 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 21185626 | | Data Table |  |
|
| 18 | [SID103173276] | Active | IC50 | 20.893 | Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique [AID408340, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 20.893 [uM] | | BioAssay | Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique | | AID | 408340 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 18448342 | | Data Table |  |
|
| 19 | [SID103173276] | Active | IC50 | 20.893 | Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique [AID408340, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 20.893 [uM] | | BioAssay | Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique | | AID | 408340 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 18448342 | | Data Table |  |
|
| 20 | [SID103173276] | Active | IC50 | 20.893 | Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique [AID408340, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 20.893 [uM] | | BioAssay | Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique | | AID | 408340 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 18448342 | | Data Table |  |
|
| 21 | [SID103173276] | Active | IC50 | 20.893 | Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique [AID408340, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 20.893 [uM] | | BioAssay | Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique | | AID | 408340 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 18448342 | | Data Table |  |
|
| 22 | [SID103173276] | Active | IC50 | 20.893 | Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique [AID408340, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 20.893 [uM] | | BioAssay | Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique | | AID | 408340 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 18448342 | | Data Table |  |
|
| 23 | [SID103173276] | Active | IC50 | 20.893 | Inhibition of human Potassium channel HERG expressed in mammalian cells [AID161281, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 20.893 [uM] | | BioAssay | Inhibition of human Potassium channel HERG expressed in mammalian cells | | AID | 161281 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 12873512 | | Data Table |  |
|
| 24 | [SID103173276] | Active | IC50 | 20.893 | Inhibition of human Potassium channel HERG expressed in mammalian cells [AID161281, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 20.893 [uM] | | BioAssay | Inhibition of human Potassium channel HERG expressed in mammalian cells | | AID | 161281 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 12873512 | | Data Table |  |
|
| 25 | [SID103173276] | Active | IC50 | 20.893 | Inhibition of human Potassium channel HERG expressed in mammalian cells [AID161281, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 20.893 [uM] | | BioAssay | Inhibition of human Potassium channel HERG expressed in mammalian cells | | AID | 161281 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 12873512 | | Data Table |  |
|
| 26 | [SID103173276] | Active | IC50 | 20.893 | Inhibition of human Potassium channel HERG expressed in mammalian cells [AID161281, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 20.893 [uM] | | BioAssay | Inhibition of human Potassium channel HERG expressed in mammalian cells | | AID | 161281 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 12873512 | | Data Table |  |
|
| 27 | [SID103173276] | Active | IC50 | 20.893 | Inhibition of human Potassium channel HERG expressed in mammalian cells [AID161281, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 20.893 [uM] | | BioAssay | Inhibition of human Potassium channel HERG expressed in mammalian cells | | AID | 161281 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 12873512 | | Data Table |  |
|
| 28 | [SID103173276] | Active | IC50 | 33.4 | Cytotoxicity against C57BL/6J mouse splenocytes after 72 hrs by alamar blue assay [AID351891, Type: Literature] | |   View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 33.4 [uM] | | BioAssay | Cytotoxicity against C57BL/6J mouse splenocytes after 72 hrs by alamar blue assay | | AID | 351891 | | BioAssay type | Literature | | Target | | | PubMed | 17846138 | | Data Table |  |
|
| 29 | [SID103173276] | Active | IC50 | 34 | Inhibition of MBTD1 by alpha-screening [AID537070, Type: Literature] | |   View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 34 [uM] | | BioAssay | Inhibition of MBTD1 by alpha-screening | | AID | 537070 | | BioAssay type | Literature | | Target | | | PubMed | 20931980 | | Data Table |  |
|
| 30 | [SID103173276] | Active | IC50 | 41 | Inhibition of L3MBTL1 by alpha-screening [AID537067, Type: Literature] | |   View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 41 [uM] | | BioAssay | Inhibition of L3MBTL1 by alpha-screening | | AID | 537067 | | BioAssay type | Literature | | Target | | | PubMed | 20931980 | | Data Table |  |
|
| 31 | [SID103173276] | Active | IC50 | 42 | Inhibition of L3MBTL3 by alpha-screening [AID537068, Type: Literature] | |   View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | IC50 | 42 [uM] | | BioAssay | Inhibition of L3MBTL3 by alpha-screening | | AID | 537068 | | BioAssay type | Literature | | Target | | | PubMed | 20931980 | | Data Table |  |
|
| 32 | [SID48415764] | Active | | | DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 48415764 | | CID | 2725 | | Outcome | Active | | BioAssay | DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database | | AID | 1195 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID85208874] | Active | | | Ligands of bioamine (Class A) GPCRs [AID2062, Type: other] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 85208874 | | CID | 2725 | | Outcome | Active | | BioAssay | Ligands of bioamine (Class A) GPCRs | | AID | 2062 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID103173276] | Active | | | Displacement of [3H](-)-trans-H2-PAT from Guinea pig histamine H2 receptors. [AID88008, Type: Literature] | |   View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | BioAssay | Displacement of [3H](-)-trans-H2-PAT from Guinea pig histamine H2 receptors. | | AID | 88008 | | BioAssay type | Literature | | Target | | | PubMed | 10447948 | | Data Table |  |
|
| 35 | [SID103173276] | Active | | | Compound was tested for the displacement of [3H]mepyramine from Histamine H1 receptor by competition binding assay [AID88625, Type: Literature] | |   View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Active | | BioAssay | Compound was tested for the displacement of [3H]mepyramine from Histamine H1 receptor by competition binding assay | | AID | 88625 | | BioAssay type | Literature | | Target | | | PubMed | 10447948 | | Data Table |  |
|
| 36 | [SID103173276] | Unspecified | IC50 | 14 | TP_TRANSPORTER: inhibition of TEA uptake (TEA: 50 uM) in OCT1-expressing MDCK cells [AID681348, Type: other] | Solute carrier family 22 member 1 [gi:81872095] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Unspecified | | IC50 | 14 [uM] | | BioAssay | TP_TRANSPORTER: inhibition of TEA uptake (TEA: 50 uM) in OCT1-expressing MDCK cells | | AID | 681348 | | BioAssay type | other | | Target | Solute carrier family 22 member 1 [gi:81872095] | | PubMed | | | Data Table |  |
|
| 37 | [SID103173276] | Unspecified | IC50 | 26 | TP_TRANSPORTER: inhibition of TEA uptake (TEA: 50 uM) in OCT2-expressing MDCK cells [AID681345, Type: other] | Solute carrier family 22 member 2 [gi:81872789] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Unspecified | | IC50 | 26 [uM] | | BioAssay | TP_TRANSPORTER: inhibition of TEA uptake (TEA: 50 uM) in OCT2-expressing MDCK cells | | AID | 681345 | | BioAssay type | other | | Target | Solute carrier family 22 member 2 [gi:81872789] | | PubMed | | | Data Table |  |
|
| 38 | [SID103173276] | Unspecified | IC50 | 50 | Concentration required to cause 50% inhibition of platelet activating factor (PAF)-induced platelet aggregation of human platelet rich plasma when challenged with 25 nM PAF. [AID89260, Type: Literature] | |   View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Unspecified | | IC50 | 50 [uM] | | BioAssay | Concentration required to cause 50% inhibition of platelet activating factor (PAF)-induced platelet aggregation of human platelet rich plasma when challenged with 25 nM PAF. | | AID | 89260 | | BioAssay type | Literature | | Target | | | PubMed | 1671420 | | Data Table |  |
|
| 39 | [SID103173276] | Unspecified | IC50 | 50 | In vitro antagonist activity, determined by 50% inhibition of PAF-induced platelet aggregation of human platelet rich plasma when challenged with PAF [AID92393, Type: Literature] | |   View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Unspecified | | IC50 | 50 [uM] | | BioAssay | In vitro antagonist activity, determined by 50% inhibition of PAF-induced platelet aggregation of human platelet rich plasma when challenged with PAF | | AID | 92393 | | BioAssay type | Literature | | Target | | | PubMed | 9934454 | | Data Table |  |
|
| 40 | [SID103173276] | Unspecified | IC50 | 61.2 | Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes by SYBR green assay [AID351893, Type: Literature] | |   View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Unspecified | | IC50 | 61.2 [uM] | | BioAssay | Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes by SYBR green assay | | AID | 351893 | | BioAssay type | Literature | | Target | | | PubMed | 17846138 | | Data Table |  |
|
| 41 | [SID103173276] | Unspecified | IC50 | 100 | Inhibition of L3MBTL4 by alpha-screening [AID537069, Type: Literature] | |   View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Unspecified | | IC50 | 100 [uM] | | BioAssay | Inhibition of L3MBTL4 by alpha-screening | | AID | 537069 | | BioAssay type | Literature | | Target | | | PubMed | 20931980 | | Data Table |  |
|
| 42 | [SID103173276] | Unspecified | Kd | 3.7e+06 | Dissociation constant (KD) of the compound [AID17268, Type: Literature] | |   View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Unspecified | | Kd | 3.7e+06 [uM] | | BioAssay | Dissociation constant (KD) of the compound | | AID | 17268 | | BioAssay type | Literature | | Target | | | PubMed | 7562938 | | Data Table |  |
|
| 43 | [SID103173276] | Unspecified | | | Partition coefficient (logD7.4) [AID19424, Type: Literature] | |   View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Unspecified | | BioAssay | Partition coefficient (logD7.4) | | AID | 19424 | | BioAssay type | Literature | | Target | | | PubMed | 11448232 | | Data Table |  |
|
| 44 | [SID103173276] | Unspecified | | | Pharmacokinetic parameter :volume apparent of distribution was reported [AID22246, Type: Literature] | |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Unspecified | | BioAssay | Pharmacokinetic parameter :volume apparent of distribution was reported | | AID | 22246 | | BioAssay type | Literature | | Target | | | PubMed | 9526560 | | Data Table |  |
|
| 45 | [SID103173276] | Unspecified | | | logD (measured by HPLC) (as log k') [AID23961, Type: Literature] | |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Unspecified | | BioAssay | logD (measured by HPLC) (as log k') | | AID | 23961 | | BioAssay type | Literature | | Target | | | PubMed | 6167716 | | Data Table |  |
|
| 46 | [SID103173276] | Unspecified | | | logD (measured by HPLC) (as log k') [AID23963, Type: Literature] | |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Unspecified | | BioAssay | logD (measured by HPLC) (as log k') | | AID | 23963 | | BioAssay type | Literature | | Target | | | PubMed | 6167716 | | Data Table |  |
|
| 47 | [SID103173276] | Unspecified | | | logD (measured by HPLC) (as log k') [AID23965, Type: Literature] | |   View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Unspecified | | BioAssay | logD (measured by HPLC) (as log k') | | AID | 23965 | | BioAssay type | Literature | | Target | | | PubMed | 6167716 | | Data Table |  |
|
| 48 | [SID103173276] | Unspecified | | | logD (measured by HPLC) (as log k') [AID23968, Type: Literature] | |   View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Unspecified | | BioAssay | logD (measured by HPLC) (as log k') | | AID | 23968 | | BioAssay type | Literature | | Target | | | PubMed | 6167716 | | Data Table |  |
|
| 49 | [SID103173276] | Unspecified | | | logD (measured by HPLC) (as log k') [AID23970, Type: Literature] | |   View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Unspecified | | BioAssay | logD (measured by HPLC) (as log k') | | AID | 23970 | | BioAssay type | Literature | | Target | | | PubMed | 6167716 | | Data Table |  |
|
| 50 | [SID103173276] | Unspecified | | | logD (measured by HPLC) (as log k') [AID23971, Type: Literature] | |   View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103173276 | | CID | 2725 | | Outcome | Unspecified | | BioAssay | logD (measured by HPLC) (as log k') | | AID | 23971 | | BioAssay type | Literature | | Target | | | PubMed | 6167716 | | Data Table |  |
|